Prevention of cisplatin-induced emesis. The Italian Group for Antiemetic Research
Roila, F.; Tonato, M.; Ballatori, E.; Del Favero, A.
Lancet 340(8825): 972
1992
ISSN/ISBN: 0140-6736 PMID: 1357367 Document Number: 403020
Document emailed within 1 workday
Related Documents
Roila, F.; Tonato, M.; Basurto, C.; Canaletti, R.; Morsia, D.; Passalacqua, R.; DiCostanzo, F.; Donati, D.; Colombo, N.; Ballatori, E. 1985: Antiemetic activity of two different high doses of metoclopramide in cisplatin-treated cancer patients: a randomized double-blind trial of the Italian Oncology Group for Clinical Research Cancer Treatment Reports 69(12): 1353-1357Hellenbrecht, D.; Saller, R. 1986: Dose-response relationships of the objective and subjective antiemetic effects and of different side effects of metoclopramide against cisplatin induced emesis Arzneimittel-Forschung 36(12): 1845-1849
Roila, F.; Ballatori, E.; Del Favero, A. 1999: Prevention of cisplatin-induced emesis by a neurokinin-1-receptor antagonist New England Journal of Medicine 340(24): 1926-1928
Voravud, N.; Suwanrusmee, H. 2000: Phase II trial of tropisetron and dexamethasone in the prevention of cisplatin-induced emesis Journal of the Medical Association of Thailand 83(6): 668-675
Agostinucci, W.A.; Gannon, R.H.; Golub, G.R.; Martin, R.S.; Schauer, P.K.; Dinonno, E.B. 1988: Continuous i.v. infusion versus multiple bolus doses of metoclopramide for prevention of cisplatin-induced emesis Clinical Pharmacy 7(6): 454-457
Tantipalakorn, C.; Srisomboon, J.; Thienthong, H.; Pantusart, A.; Suprasert, P.; Saereesongkhun, C.; Eamtang, S.; Sutthichat, A.; Pautad, N. 2004: Comparison of oral versus intravenous ramosetron in prevention of acute cisplatin-induced emesis: a randomized controlled trial Journal of the Medical Association of Thailand 87(2): 119-125
Garcia-del-Muro, X.; Vadell, C.; Pérez Manga, G.; Bover, I.; Rifá, J.; Beltrán, M.; Barros, M.M.; Germá, J.R.; Fabregat, X.; Moreno, V.; Salvador, A.; Viladiu, P. 1998: Randomised double-blind study comparing tropisetron alone and in combination with dexamethasone in the prevention of acute and delayed cisplatin-induced emesis European Journal of Cancer 34(1): 193-195
Takeda, N.; Hasegawa, S.; Morita, M.; Horii, A.; Uno, A.; Yamatodani, A.; Matsunaga, T. 1995: Neuropharmacological mechanisms of emesis. I. Effects of antiemetic drugs on motion- and apomorphine-induced pica in rats Methods and Findings in Experimental and Clinical Pharmacology 17(9): 589-590
Gylys, J.A.; Doran, K.M.; Buyniski, J.P. 1979: Antagonism of cisplatin induced emesis in the dog Research Communications in Chemical Pathology and Pharmacology 23(1): 61-68
Li, Y.T.; Mau, Y.K.; Hsu, K.P. 1991: Control of cisplatin-induced delayed emesis Zhonghua Yi Xue Za Zhi 48(6): 451-455
Heron, J.F. 1995: Single-agent oral granisetron for the prevention of acute cisplatin-induced emesis: a double-blind, randomized comparison with granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone Seminars in Oncology 22(4 Suppl. 10): 24-30
Ito, J.; Okada, M.; Abo, T.; Okamoto, Y.; Yamashita, T.; Takahashi, K. 1987: Experimental study on the control of cisplatin-induced emesis in dogs Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(3 Part 1): 706-710
Plezia, P.M.; Alberts, D.S.; Kessler, J.; Aapro, M.S.; Graham, V.; Surwit, E.A. 1984: Immediate termination of intractable vomiting induced by cisplatin combination chemotherapy using an intensive five-drug antiemetic regimen Cancer Treatment Reports 68(12): 1493-1495
Bhandari, P.; Gupta, Y.K.; Seth, S.D. 1989: BRL 43694, a new 5HT3 receptor antagonist, prevents cisplatin-induced emesis in dogs Methods and Findings in Experimental and Clinical Pharmacology 11(5): 361-363
Akaza, H.; Machida, T.; Akasaka, Y.; Fukuii, I.; Kinouchi, T.; Ozono, S. 1995: The antiemetic effect, safety and usefulness of tropisetron capsule in the treatment of nausea and vomiting induced by lower multiple dose of cisplatin Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(8): 1063-1072
Cupissol, D.R.; Serrou, B.; Caubel, M. 1990: The efficacy of granisetron as a prophylactic anti-emetic and intervention agent in high-dose cisplatin-induced emesis European Journal of Cancer 26(Suppl 1): S23-S27
Sorbe, B.; Hallén, C. 1991: Betamethasone-dixyrazine versus betamethasone-metoclopramide as antiemetic treatment of cisplatin-doxorubicin-induced nausea in ovarian carcinoma patients European Journal of Gynaecological Oncology 12(1): 31-37
Bhatia, A.; Tripathi, K.D.; Sharma, M. 2003: Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose & high dose cisplatin chemotherapy Indian Journal of Medical Research 118: 33-41
Huo, M.L.; Wang, Y.S.; Wang, P.; Xiang, Y.S.; Wang, J.G. 1986: Emesis induced by cisplatin and sulfato-1, sulfato-1,2-diaminocyclohexane platinum in dogs and their antiemetics Zhongguo Yao Li Xue Bao 7(2): 182-184
Clerico, M.; Bertetto, O.; Morandini, M.P.; Cardinali, C.; Giaccone, G. 1993: Antiemetic activity of oral lorazepam in addition to methylprednisolone and metoclopramide in the prophylactic treatment of vomiting induced by cisplatin. A double-blind, placebo-controlled study with crossover design Tumori 79(2): 119-122